3C
CELG

361 Capital’s Celgene Corp CELG Stock Holding History

361 Capital’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-24,356
Closed -$2.18M – 456
2018
Q3 		$2.18M Buy
+24,356
New +$2.15M 0.47% 35
2017
Q4 		– Sell
-29,830
Closed -$4.35M – 341
2017
Q3 		$4.35M Sell
29,830
-31,154
-51% -$4.24M 0.83% 16
2017
Q2 		$7.92M Buy
60,984
+6,468
+12% +$793K 1.34% 22
2017
Q1 		$6.78M Buy
54,516
+3,108
+6% +$372K 1.45% 22
2016
Q4 		$5.95M Buy
+51,408
New +$5.73M 1.41% 36

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

361 Capital's CELG Position: Q4 2018 in Review

361 Capital sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 24,356 shares — an estimated $2.18M sold.

361 Capital first reported a position in CELG in Q4 2016 and held it in 5 quarters. The position peaked at $7.92M in Q2 2017. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • 361 Capital reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • 361 Capital sold 24,356 Celgene Corp shares in Q4 2018, an estimated $2.18M.
  • 361 Capital first reported a position in Celgene Corp in Q4 2016 and held it in 5 quarters.
  • 361 Capital's Celgene Corp position peaked at $7.92M in Q2 2017.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on 361 Capital's 13F filing for Q4 2018, filed 8 Feb 2019.